Serum S100β is a Better Biomarker than Neuron-Specific Enolase for Sepsis-Associated Encephalopathy and Determining Its Prognosis: A Prospective and Observational Study

Title
Serum S100β is a Better Biomarker than Neuron-Specific Enolase for Sepsis-Associated Encephalopathy and Determining Its Prognosis: A Prospective and Observational Study
Authors
Keywords
S100β, Neuro-specific enolase, Sepsis-associated encephalopathy, Biomarker, Sensitivity, Specificity
Journal
NEUROCHEMICAL RESEARCH
Volume 39, Issue 7, Pages 1263-1269
Publisher
Springer Nature
Online
2014-04-23
DOI
10.1007/s11064-014-1308-0

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now